Dysregulation of ADAR1 and ADAR2 deaminase A-to-I editing is now implicated in a wide range of diseases, including immune and inflammatory illness, neurological conditions (including schizophrenia), viral infections, and cancers [95,96]. This evidence concerns the gene ADAR and cancer.